Navigating Payor Barriers to Access of Oncology Pharmaceuticals: Real-World Case Approach
Jorge Garcia, PharmD, MS, MHA, MBA, FACHE
Myelodysplastic Syndrome: Challenges, Current Standard Therapy and Future Directions
Rami Komrokji, MD
Lack of Access to Novel Cancer Therapies: How to Deal and Approach this Problem? Diversity, Equity, & Inclusion
Edith Peterson Mitchell, MD, MACP, FCPP, FRCP [London]
Identifying and Targeting Mechanisms of Resistance to 3rd Generation EGFR Inhibitors
Ravi Salgia, MD
Geriatric Oncology: Pitfalls to Deliver Good Care in the Elderly Cancer Patient
Tom Reske, MD, PhD, FACP, CMD, AGSF
